GP KFPs / SAQs · mental-health
Post-traumatic stress disorder — KFP-style written assessment
KFP-style staged scenarios on PTSD in general practice: recognising masked PTSD at a script-renewal visit, sequencing trauma-focused therapy against pharmacotherapy, managing nightmares after partial SSRI response, and handling the cannabis request with evidence-honest counsel.
On this page
Study tools
Target exams
KFP 1 (10 marks)
A 31-year-old teacher attends for repeat antidepressant scripts. Her dispensed history shows sertraline 100 mg continued for two years. On direct questioning she describes an armed robbery at her previous workplace four years ago. She still has monthly nightmares of the event, avoids shopping centres, feels estranged from her partner, and startles at sudden noise. She has never been asked about the robbery before and says she assumed "the tablets were for stress". [1][5]
- List the features from this history that satisfy each DSM-5 symptom cluster of PTSD. (4 marks)
- Give two reasons her current management is incomplete despite two years of sertraline. (2 marks)
- Outline your first-line management plan, naming the specific therapy type and its expected benefit. (3 marks)
- State one screening instrument appropriate to confirm symptom burden and one limitation of it. (1 mark)
Model answers
- Intrusion: nightmares of the event, startle at reminders. Avoidance: avoiding shopping centres (trauma-associated public spaces). Negative alterations in cognition/mood: estrangement from partner. Hyperarousal: exaggerated startle, sleep disturbance.[1]
- First, PTSD was never diagnosed or treated with first-line therapy — SSRIs alone are second-line and her symptoms persist on adequate dose and duration. Second, no trauma-focused psychotherapy has ever been offered despite strong evidence (TF-CBT SMD -1.62 vs usual care; EMDR SMD -1.17; NNT below 4 for diagnosis loss).[2][3]
- Refer for trauma-focused CBT or EMDR with a trained therapist (8-12 sessions typical), continue sertraline meanwhile, assess suicidality and substance use, and review at completion. Network meta-analysis ranks EMDR and TF-CBT highest for symptom reduction and remission; head-to-head data show equivalence, so access decides.[4][5]
- PCL-5 quantifies symptom severity and tracks change, but validation studies show moderate diagnostic utility (one treatment-seeking sample AUC 0.658) — screen and monitor, never diagnose from the score alone.
References8ShowHide
- [1]Phelps AJ, et al. Australian guidelines for the prevention and treatment of posttraumatic stress disorder: Updates in the third edition. Aust N Z J Psychiatry, 2022.PMID 34448406
- [2]Bisson JI, et al. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev, 2013.PMID 24338345
- [3]Cusack K, et al. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev, 2016.PMID 26574151
- [4]Mavranezouli I, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med, 2020.PMID 32063234
- [5]Williams T, et al. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev, 2026.PMID 42206608
- [6]Raskind MA, et al. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med, 2018.PMID 29414272
- [7]O'Neil ME, et al. Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review. Ann Intern Med, 2017.PMID 28806794
- [8]Kroeger CM, et al. Post-traumatic stress disorder in Australia: Results from the 2020-2022 National Study of Mental Health and Wellbeing. Aust N Z J Psychiatry, 2026.PMID 42303590